Filtern
Volltext vorhanden
- ja (46)
Gehört zur Bibliographie
- ja (46)
Dokumenttyp
Sprache
- Englisch (46) (entfernen)
Schlagworte
- biofabrication (5)
- hyaluronic acid (5)
- bioprinting (4)
- chondrogenic differentiation (3)
- extracellular matrix (3)
- melt electrowriting (3)
- 3D printing (2)
- MSC (2)
- bioink (2)
- bone cement (2)
- dual-stage crosslinking (2)
- hydrogels (2)
- in vitro (2)
- magnesium phosphate cement (2)
- melt electrowriting (MEW) (2)
- scaffolds (2)
- stem cells (2)
- therapy (2)
- tissue engineering (2)
- (AB)\(_{n}\) segmented copolymers (1)
- 3D models (1)
- 3D scaffolds (1)
- ACPC (1)
- ALI culture (1)
- Brushite (1)
- ECM (1)
- FluidFM technology (1)
- Fluorescence Microscopy (1)
- HEMA (1)
- MPI (1)
- MPS (1)
- Mitotane (1)
- Schiff base chemistry (1)
- actin (1)
- acute myeloid leukaemia (1)
- additive manufacturing (1)
- adhesion dynamics (1)
- adipose tissue (1)
- adipose-derived stromal cells (1)
- adrenal gland (1)
- agarose (1)
- alveolar‐capillary barrier (1)
- anisotropic porous structures (1)
- atomic force microscopy (1)
- azlactone (1)
- baghdadite (1)
- balloon kyphoplasty (1)
- bending strength (1)
- bio-printability (1)
- biocompatibility (1)
- biodegradable polymers (1)
- biofabricated vascular graft (1)
- bioinspired membrane (1)
- biological models (1)
- biophysics (1)
- bone adhesive (1)
- bone critical size defect (1)
- bone model (1)
- breast cancer model (1)
- brushite cement (1)
- calcium phosphate (1)
- calcium phosphate cement (1)
- calcium phosphate cements (1)
- cancer (1)
- cardiovascular pharmacology (1)
- cartilage (1)
- cartilage repair (1)
- cell elongation (1)
- cell printing (1)
- chemokines (1)
- chondrocyte (1)
- chondrocytes (1)
- chondroprogenitors (1)
- click chemistry (1)
- co-culture (1)
- coatings (1)
- cochlea (1)
- collagen sponge (1)
- combination of physical vapor deposition and electrochemical etching (1)
- composite material (1)
- compressive strength (1)
- connective tissue (1)
- crosslinked coating (1)
- cryostructured scaffolds (1)
- cryostructuring (1)
- cyclic mechanical stretch (1)
- cyclic stretch (1)
- cyto-compatibility (1)
- deafness (1)
- decellularization (1)
- defects (1)
- defined humanized test system (1)
- degradable implant (1)
- detachment force quantification (1)
- dihydrate cement (1)
- disease models (1)
- drug delivery (1)
- dual setting (1)
- dual setting system (1)
- electron microscopy (1)
- embedded templating (1)
- endothelial progenitor cells (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- extrusion-based 3D printing (1)
- factor-I (1)
- fiber reinforcement (1)
- focal adhesions (1)
- force (1)
- free radical polymerization (1)
- functionalization (1)
- gels (1)
- heart-failure (1)
- heterotypic scaffold design (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human macrophages (1)
- human neutrophil elastase (HNE) (1)
- hybrid fabrication (1)
- hybrid polymers (1)
- hydraulic reactivity (1)
- hydrogel (1)
- hydrogel formation (1)
- hydroxyapatite (1)
- hypoxia (1)
- imaging agents (1)
- immunomodulation (1)
- in situ guided tissue regeneration (1)
- in vitro cell‐stretch model (1)
- inflammation (1)
- inflammatory response (1)
- inner ear (1)
- intercellular adhesion (1)
- lectin (1)
- left-ventricular function (1)
- lung cell model (1)
- macrophage polarization (1)
- macrophages (1)
- magnetic properties (1)
- mature cell-cell contacts (1)
- mechanical activation (1)
- mechanical properties (1)
- medicine (1)
- melt electrowriting (1)
- melt electrofibrillation (1)
- mesenchymal tissues (1)
- microfibers (1)
- microfluidics (1)
- microstructures (1)
- microvasculature (1)
- migration (1)
- mineralization (1)
- minipig (1)
- modelling (1)
- morphology controls (1)
- mucin (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- nanostructures (1)
- nanotopographical surfaces (1)
- networks (1)
- organ-on-a-chip (1)
- organoids (1)
- osteochondral defect (1)
- osteogenesis (1)
- oxidation (1)
- particle study (1)
- peptide conjugation (1)
- peptide immobilization (1)
- phase conversion (1)
- photopolymerization (1)
- phytic acid (1)
- poly(2-ethyl-2-oxazoline) (1)
- polyacrylic acid (1)
- polymer-analogue functionalization (1)
- polymeric matrix (1)
- polyoxazoline (1)
- polyoxazolines (1)
- porosity (1)
- primary vascular smooth muscle‐like cells (vSMCs) (1)
- printability (1)
- rat model (1)
- recruitment (1)
- regenerative medicine (1)
- remodelling (1)
- repair (1)
- rhBMP–2 (1)
- rheology (1)
- sacrificial printing (1)
- serial block face EM (1)
- shape fidelity (1)
- shear thinning (1)
- silicones (1)
- silk fibroin scaffolds (1)
- solution electrospinning (1)
- spheroids (1)
- starPEG hydrogel (1)
- stem cell niche (1)
- stemness (1)
- stimulation (1)
- stress (1)
- sugar glass printing (1)
- synergistic reinforcement (1)
- systematic investigations (1)
- tension (1)
- tethering (1)
- thermoresponsive hydrogel (1)
- thiol-ene (1)
- tissue morphogenesis (1)
- traction (1)
- transforming growth factor-beta 1 (1)
- transplantation (1)
- tunable ultra‐thin biphasic membrane (1)
- unidirectional freezing (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- zonal (1)
- zonal construct (1)
- α-tricalcium phosphate (1)
Institut
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (42)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (5)
- Institut für Funktionsmaterialien und Biofabrikation (4)
- Lehrstuhl für Orthopädie (4)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (4)
- Institut für Anatomie und Zellbiologie (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Institut für Organische Chemie (1)
- Institut für Systemimmunologie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
The bioprinting roadmap
(2020)
This bioprinting roadmap features salient advances in selected applications of the technique and highlights the status of current developments and challenges, as well as envisioned advances in science and technology, to address the challenges to the young and evolving technique. The topics covered in this roadmap encompass the broad spectrum of bioprinting; from cell expansion and novel bioink development to cell/stem cell printing, from organoid-based tissue organization to bioprinting of human-scale tissue structures, and from building cell/tissue/organ-on-a-chip to biomanufacturing of multicellular engineered living systems. The emerging application of printing-in-space and an overview of bioprinting technologies are also included in this roadmap. Due to the rapid pace of methodological advancements in bioprinting techniques and wide-ranging applications, the direction in which the field should advance is not immediately clear. This bioprinting roadmap addresses this unmet need by providing a comprehensive summary and recommendations useful to experienced researchers and newcomers to the field.
Adrenocortical carcinoma (ACC) is a malignant tumor originating from the adrenal gland cortex with a heterogeneous but overall dismal prognosis in advanced stages. For more than 50 years, mitotane has remained a cornerstone for the treatment of ACC as adjuvant and palliative therapy. It has a very poor aqueous solubility of 0.1 mg/l and high partition coefficient in octanol/water (log P) value of 6. The commercially available dosage form is 500 mg tablets (Lysodren®). Even at doses up to 6 g/day (12 tablets in divided doses) for several months, > 50% patients do not achieve therapeutic plasma concentration > 14 mg/l due to poor water solubility, large volume of distribution and inter/intra-individual variability in bioavailability. This article aims to give a concise update of the clinical challenges associated with the administration of high-dose mitotane oral therapy which encompass the issues of poor bioavailability, difficult-to-predict pharmacokinetics and associated adverse events. Moreover, we present recent efforts to improve mitotane formulations. Their success has been limited, and we therefore propose an injectable mitotane formulation instead of oral administration, which could bypass many of the main issues associated with high-dose oral mitotane therapy. A parenteral administration of mitotane could not only help to alleviate the adverse effects but also circumvent the variable oral absorption, give better control over therapeutic plasma mitotane concentration and potentially shorten the time to achieve therapeutic drug plasma concentrations considerably.
Mitotane as tablet form is currently the standard treatment for adrenocortical carcinoma. It has been used for 5 decades but suffers from highly variable responses in patients, subsequent adverse effects and overall lower response rate. This can be fundamentally linked to the exceedingly poor water solubility of mitotane itself. In terms of enhancing water solubility, a few research groups have attempted to develop better formulations of mitotane to overcome the issues associated with tablet dosage form. However, the success rate was limited, and these formulations did not make it into the clinics. In this article, we have comprehensively reviewed the properties of these formulations and discuss the reasons for their limited utility. Furthermore, we discuss a recently developed mitotane nanoformulation that led us to propose a novel approach to mitotane therapy, where intravenous delivery supplements the standard oral administration. With this article, we combine the current state of knowledge as a single piece of information about the various problems associated with the use of mitotane tablets, and herein we postulate the development of a new injectable mitotane formulation, which can potentially circumvent the major problems associated to mitotane's poor water solubility.
Dual setting cements composed of an in situ forming hydrogel and a reactive mineral phase combine high compressive strength of the cement with sufficient ductility and bending strength of the polymeric network. Previous studies were focused on the modification with non-degradable hydrogels based on 2-hydroxyethyl methacrylate (HEMA). Here, we describe the synthesis of suitable triblock degradable poly(ethylene glycol)-poly(lactide) (PEG-PLLA) cross-linker to improve the resorption capacity of such composites. A study with four different formulations was established. As reference, pure hydroxyapatite (HA) cements and composites with 40 wt% HEMA in the liquid cement phase were produced. Furthermore, HEMA was modified with 10 wt% of PEG-PLLA cross-linker or a test series containing only 25% cross-linker was chosen for composites with a fully degradable polymeric phase. Hence, we developed suitable systems with increased elasticity and 5-6 times higher toughn ess values in comparison to pure inorganic cement matrix. Furthermore, conversion rate from alpha-tricalcium phosphate (alpha-TCP) to HA was still about 90% for all composite formulations, whereas crystal size decreased. Based on this material development and advancement for a dual setting system, we managed to overcome the drawback of brittleness for pure calcium phosphate cements.
Supplement-free induction of cellular differentiation and polarization solely through the topography of materials is an auspicious strategy but has so far significantly lagged behind the efficiency and intensity of media-supplementation-based protocols. Consistent with the idea that 3D structural motifs in the extracellular matrix possess immunomodulatory capacity as part of the natural healing process, it is found in this study that human-monocyte-derived macrophages show a strong M2a-like prohealing polarization when cultured on type I rat-tail collagen fibers but not on collagen I films. Therefore, it is hypothesized that highly aligned nanofibrils also of synthetic polymers, if packed into larger bundles in 3D topographical biomimetic similarity to native collagen I, would induce a localized macrophage polarization. For the automated fabrication of such bundles in a 3D printing manner, the strategy of “melt electrofibrillation” is pioneered by the integration of flow-directed polymer phase separation into melt electrowriting and subsequent selective dissolution of the matrix polymer postprocessing. This process yields nanofiber bundles with a remarkable structural similarity to native collagen I fibers, particularly for medical-grade poly(ε-caprolactone). These biomimetic fibrillar structures indeed induce a pronounced elongation of human-monocyte-derived macrophages and unprecedentedly trigger their M2-like polarization similar in efficacy as interleukin-4 treatment.
Despite advances in cartilage repair strategies, treatment of focal chondral lesions remains an important challenge to prevent osteoarthritis. Articular cartilage is organized into several layers and lack of zonal organization of current grafts is held responsible for insufficient biomechanical and biochemical quality of repair-tissue. The aim was to develop a zonal approach for cartilage regeneration to determine whether the outcome can be improved compared to a non-zonal strategy. Hydrogel-filled polycaprolactone (PCL)-constructs with a chondrocyte-seeded upper-layer deemed to induce hyaline cartilage and a mesenchymal stromal cell (MSC)-containing bottom-layer deemed to induce calcified cartilage were compared to chondrocyte-based non-zonal grafts in a minipig model. Grafts showed comparable hardness at implantation and did not cause visible signs of inflammation. After 6 months, X-ray microtomography (µCT)-analysis revealed significant bone-loss in both treatment groups compared to empty controls. PCL-enforcement and some hydrogel-remnants were retained in all defects, but most implants were pressed into the subchondral bone. Despite important heterogeneities, both treatments reached a significantly lower modified O’Driscoll-score compared to empty controls. Thus, PCL may have induced bone-erosion during joint loading and misplacement of grafts in vivo precluding adequate permanent orientation of zones compared to surrounding native cartilage.
As one kind of “smart” material, thermogelling polymers find applications in biofabrication, drug delivery and regenerative medicine. In this work, we report a thermosensitive poly(2-oxazoline)/poly(2-oxazine) based diblock copolymer comprising thermosensitive/moderately hydrophobic poly(2-N-propyl-2-oxazine) (pPrOzi) and thermosensitive/moderately hydrophilic poly(2-ethyl-2-oxazoline) (pEtOx). Hydrogels were only formed when block length exceeded certain length (≈100 repeat units). The tube inversion and rheological tests showed that the material has then a reversible sol-gel transition above 25 wt.% concentration. Rheological tests further revealed a gel strength around 3 kPa, high shear thinning property and rapid shear recovery after stress, which are highly desirable properties for extrusion based three-dimensional (3D) (bio) printing. Attributed to the rheology profile, well resolved printability and high stackability (with added laponite) was also possible. (Cryo) scanning electron microscopy exhibited a highly porous, interconnected, 3D network. The sol-state at lower temperatures (in ice bath) facilitated the homogeneous distribution of (fluorescently labelled) human adipose derived stem cells (hADSCs) in the hydrogel matrix. Post-printing live/dead assays revealed that the hADSCs encapsulated within the hydrogel remained viable (≈97%). This thermoreversible and (bio) printable hydrogel demonstrated promising properties for use in tissue engineering applications.